Sustained market demand led to impressive revenue growth in the automotive and consumer goods sectors. In contrast, while the banking secto...

India and the SACU group will sign terms of reference for trade talks. Negotiations for a preferential trade agreement are expected to begi...

2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

To bolster India's medical device industry, a strategic pivot toward international markets and enhanced global presence is essential. Foste...

In a bid to enhance economic ties, Uzbekistan is inviting Indian investments into its mining and metallurgy sectors, highlighting lucrative...

School Assembly News Headlines: The Lok Sabha in India has successfully passed a significant bill aimed at modernizing banking evidence law...

FBI Director Kash Patel has initiated new law enforcement partnerships with China and Russia. These collaborations focus on transnational c...

Indian companies are increasingly pursuing strategic overseas acquisitions. They now focus on acquiring capabilities and technology rather ...

The United States revoked Brazil's ambassador's visa in retaliation for visa denials. Brazil had refused entry to two American diplomats ah...

India is planning a second phase for its production-linked incentive programme. This new phase will support high-performing sectors and red...

India's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...

Several Indian family businesses received awards for their significant contributions. Serum Institute of India was honored for philanthropi...

Amid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....

Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...

US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...

The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...